| Application no. and date | 13760180.3 (espacenet) (Federated) (European Patent Register), 20130828 | | Patent/reg. no. and date | DK/EP 2890397, 20190619 | | Publication date | 20150708 | | Priority no. and date | US 201261695949 P, 20120831, US 201313842906, 20130315 | | EP pub. no. and date |
EP 2890397 20150708 | | Effective date | | | Applicant/owner | Bayer HealthCare LLC, 100 Bayer Boulevard
Whippany, NJ 07981-0915, US | | Applicant ref. no. | 1486624 | | Inventor | MA, Xinghang, 2511 Valentano Drive
Dublin, CA 94568, US,
XIANG, Jun, 1382 Contra Costa Boulevard 65
Pleasant Hill, CA 94523, US,
NIU, Jianjie, 21949 Pheasant Woods Drive
Castro Valley, CA 94552, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 5/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTIPROLACTINRECEPTOR-ANTISTOFFORMULERING | | Int. application no. | US2013056976 | | Int. publication no. | WO2014036076 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
